ArticleAIDS and behavior2026
PrEP Use Likelihood Among People Who Use Opioid Drugs: Understanding Clinical Correlates Along the Opioid Use Disorder Treatment Cascade.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
People with opioid use disorder (PWOUD) are at high risk of HIV infection, yet uptake of PrEP remains low in PWOUD. To understand opportunities to increase PrEP engagement, this cross-sectional study sought to examine clinical correlates of perceived PrEP use likelihood in a sample of PWOUD along the OUD Treatment Cascade. We enrolled 120 PWOUD with past-6-month injection drug use (IDU) or condomless sex in a cross-sectional survey study. Participants were recruited from sites serving PWOUD in the Boston area, including substance use disorder (SUD) treatment programs and harm reduction service providers. PWOUD characterized their substance use and treatment history, perceived risk of acquiring HIV, and likelihood of using oral and long-acting injectable (LAI) PrEP. Ordinal logistic regression and Pearson correlations were used to examine correlates of likelihood of using oral and LAI-PrEP. Contrary to hypotheses, current MOUD engagement was not associated with perceived likelihood of using oral or LAI-PrEP. More recent IDU was associated with greater likelihood of using both oral PrEP (OR = 0.98, 95% CI: 0.97, 0.99) and LAI-PrEP (OR = 0.99, 95% CI: 0.98, 1.00). PWOUD who received past-year emergency department-based SUD treatment endorsed lower likelihood of using LAI-PrEP (OR = 0.40, 95% CI: 0.19, 0.84). Among PWOUD, a greater number of sex partners was a stronger correlate of perceived risk of acquiring HIV than IDU-related risk behaviors. Results suggest opportunities to engage PWOUD at greatest HIV risk in PrEP care; findings also suggest need for education interventions to inform judgments of HIV risk among PWOUD.
Indexed as
Identifiers
40826261What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.